Cargando…
Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques
BACKGROUND: There are currently no licensed vaccines available for prevention of botulism in humans. The vaccination is not desirable due to expanding therapeutic indications of botulinum toxins. The only available specific treatment for botulism is antitoxin to remove circulating toxin, thus, preve...
Autores principales: | Kodihalli, Shantha, Emanuel, Andrew, Takla, Teresa, Hua, Yi, Hobbs, Charles, LeClaire, Ross, O’Donnell, Denise C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5699824/ https://www.ncbi.nlm.nih.gov/pubmed/29166654 http://dx.doi.org/10.1371/journal.pone.0186892 |
Ejemplares similares
-
Efficacy of equine botulism antitoxin in botulism poisoning in a guinea pig model
por: Emanuel, Andrew, et al.
Publicado: (2019) -
Therapeutic efficacy of equine botulism heptavalent antitoxin against all seven botulinum neurotoxins in symptomatic guinea pigs
por: Barker, Douglas, et al.
Publicado: (2019) -
Exposure‐Response Modeling and Simulation to Support Human Dosing of Botulism Antitoxin Heptavalent Product
por: Beliveau, Martin, et al.
Publicado: (2022) -
Cost savings associated with timely treatment of botulism with botulism antitoxin heptavalent product
por: Anderson, Deborah M., et al.
Publicado: (2019) -
Botulism in Spain: Epidemiology and Outcomes of Antitoxin Treatment, 1997–2019
por: Peñuelas, Marina, et al.
Publicado: (2022)